Commitments and Contingencies (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
| Commitments and Contingencies (Textual) | ||
| Rent expense | $ 171,294 | $ 107,385 |
| 2011 Exclusive Agreement [Member] | ||
| Commitments and Contingencies (Textual) | ||
| Milestone payment | $ 765,000 | |
| License reduced percentage | 50.00% | |
| Aggregate maintenance fees for first five years | $ 80,000 | |
| Maintenance fees annually after first five years | $ 50,000 | |
| Royalty percentage | 2.00% | |
| Minimum royalty expense | $ 75,000 | |
| Royalty description | The Company is required to pay royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of phase II clinical trials to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of phase I clinical trials). | |
| 2013 Exclusive Agreement [Member] | ||
| Commitments and Contingencies (Textual) | ||
| Milestone payment | $ 765,000 | |
| License reduced percentage | 50.00% | |
| Aggregate maintenance fees for first three years | $ 7,500 | |
| Maintenance fees annually after first five years | $ 5,000 | |
| Royalty percentage | 2.00% | |
| Minimum royalty expense | $ 75,000 | |
| Royalty description | The Company is required to pay The Regents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of phase II clinical trials to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of phase I clinical trials). | |
| License costs | $ 10,000 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage of license reduced. No definition available.
|
| X | ||||||||||
- Definition Amount of maintenance. No definition available.
|
| X | ||||||||||
- Definition Description of the royalty payments. No definition available.
|
| X | ||||||||||
- Definition Royalty percentage. No definition available.
|
| X | ||||||||||
- Definition Total costs related to services rendered by an entity during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Cost of generating revenue from multiple-deliverable arrangements that include licensing fees and maintenance revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Maintenance revenue is derived from maintenance services provided under contracts or arrangements with clients. Services may include the maintenance of software, plant and equipment, and facilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Maintenance costs incurred and directly related to services rendered by an entity during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|